Advertisement

Lipid metabolism in diabetes

Chapter
  • 44 Downloads

Abstract

Diabetes and lipid metabolism has been the subject of a number of recent reviews1-3. It has been suggested4 that abnormalities in lipoprotein metabolism can be understood by examining four sites of regulation of plasma lipoprotein transport:
  1. (1)

    production of triglyceride-rich lipoproteins,

     
  2. (2)

    lipoprotein lipase mediated triglyceride removal,

     
  3. (3)

    remnant catabolism,

     
  4. (4)

    extra-hepatic cholesterol rich lipoprotein catabolism.

     

Keywords

Lipid Metabolism Lipoprotein Lipase Plasma Triglyceride Cholesterol Metabolism Insulin Deficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nikkila, E. A. (1973). Triglyceride metabolism in diabetes mellitus. Progr. Biochem. Pharmacol., 8, 271Google Scholar
  2. 2.
    Stout, R. W., Bierman, E. L. and Brunzell, J. D. (1975). Atherosclerosis and disorders of lipid metabolism in diabetes. In Vallance-Owen, J. (ed.) Diabetes — its Physiological and Biochemical Basi., pp. 125–69. (Lancaster: MTP Press)Google Scholar
  3. 3.
    Wilson, D. A. and Brown, W. V. (1978). Lipids and lipoproteins in diabetes mellitus. Adv. Mod. Nutr., 2, 127Google Scholar
  4. 4.
    Brunzell, J. D., Chait, A. and Bierman, E. L. (1978). Pathophysiology of lipoprotein transport. Metabolism, 27, 1109PubMedCrossRefGoogle Scholar
  5. 5.
    Bierman, E. L., Porte, D., Jr and Bagdade, J. D. (1970). Hypertriglyceridemia and glucose intolerance in man. In Jeanrenaud, B. and Hepp, D. (eds.) Adipose Tissu., pp. 209–12. (New York: Academic Press)Google Scholar
  6. 6.
    Bagdade, J. D., Bierman, E. L. and Porte, D. Jr. (1971). Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia. Diabetes, 20, 664PubMedGoogle Scholar
  7. 7.
    Olefsky, J. M., Farquhar, J. W. and Reaven, G. M. (1974). Reappraisal of the role of insulin in hypertriglyceridemia. Am. J. Med., 57, 551PubMedCrossRefGoogle Scholar
  8. 8.
    Brunzell, J. D. and Bierman, E. L. (1977). Plasma triglyceride and insulin levels in familial hypertriglyceridemia. Ann. Intern. Med., 87, 198PubMedGoogle Scholar
  9. 9.
    Kyner, J. L., Levy, R. I., Soeldner, J. S., Gleason, R. E. and Fredrickson, D. S. (1976). Lipid, glucose and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects. J. Lab. Clin. Med., 88, 345PubMedGoogle Scholar
  10. 10.
    Tan, M. H., Havel, R. J., Gerich, J. E., Soeldner, J. S. and Kane, J. P. (1980). Pancreatic alpha and beta cell function in familial dysbetalipoproteinemia. Horm. Metab. Res., 12, 421PubMedCrossRefGoogle Scholar
  11. 11.
    Topping, D. L. and Mayes, P. A. (1972). The immediate effects of insulin and fructose on the metabolism of the perfused liver: changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem. J., 126, 295Google Scholar
  12. 12.
    Reaven, E. P. and Reaven, G. M. (1974). Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rats. Effect of diet and duration of insulin deficiency. J. Clin. Invest., 54, 1167PubMedCrossRefGoogle Scholar
  13. 13.
    Balasse, E. O., Bier, D. M. and Havel, R. J. (1972). Early effects of antiinsulin serum on hepatic metabolism of plasma free fatty acids in dogs. Diabetes, 21, 280PubMedGoogle Scholar
  14. 14.
    Renold, A. E., Crofford, O. B., Stauffacher, W. and Jeanrenaud, B. (1965). Hormonal control of adipose tissue metabolism, with special reference to the effects of insulin. Diabetologia, 1, 4CrossRefGoogle Scholar
  15. 15.
    Gross, R. C. and Carlson, L. A. (1968). Metabolic effects of nicotinic acid in acute insulin deficiency in the rat. Diabetes, 17, 353PubMedGoogle Scholar
  16. 16.
    Bagdade, J. D., Porte, D. Jr. and Bierman, E. L. (1968). Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes, 17, 127PubMedGoogle Scholar
  17. 17.
    Pykalisto, O. J., Smith, P. H. and Brunzell, J. D. (1975). Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal and diet-induced activity. J. Clin. Invest., 56, 1108PubMedCrossRefGoogle Scholar
  18. 18.
    Chen, Y. I., Risser, T. R., Cully, M. and Reaven, G. M. (1979). Is the hypertriglyceridemia associated with insulin deficiency caused by decreased lipoprotein lipase activity? Diabetes, 28, 893PubMedGoogle Scholar
  19. 19.
    Greenfield, M., Kolterman, O., Olefsky, J. and Reaven, G. M. (1980). Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia, 18, 441PubMedCrossRefGoogle Scholar
  20. 20.
    Bagdade, J. D., Porte, D. Jr. and Bierman, E. L. (1967). Diabetic lipemia. A form of acquired fat-induced lipemia. N. Engl. J. Med., 276, 427PubMedCrossRefGoogle Scholar
  21. 21.
    Brunzell, J. D., Porte, D. Jr. and Bierman, E. L. (1975). Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). Metabolism, 24, 1123PubMedCrossRefGoogle Scholar
  22. 22.
    Lewis, B., Mancini, M., Mattock, M., Chait, A. and Fraser, T. R. (1972). Plasma triglyceride and fatty acid metabolism in diabetes mellitus. Eur. J. Clin. Invest., 2, 445PubMedCrossRefGoogle Scholar
  23. 23.
    Nikkila, E. A. and Kekki, M. (1973). Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism, 22, 1PubMedCrossRefGoogle Scholar
  24. 24.
    Brunzell, J. D., Porte, D. Jr and Bierman, E. L. (1979). Abnormal lipoprotein-lipase- mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia. Metabolism, 28, 901PubMedCrossRefGoogle Scholar
  25. 25.
    Taskinen, M.-R. and Nikkila, E. A. (1979). Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Diabetologia, 17, 351PubMedCrossRefGoogle Scholar
  26. 26.
    Clarenburg, R. and Chaikoff, I. L. (1966). Cholesterol synthesis in liver of alloxan- diabetic rat: role of diet. Am. J. Physiol., 210, 37Google Scholar
  27. 27.
    Burns, B. J. and Elwood, J. C. (1969). Lipid metabolism in kidney and liver tissue from normal and diabetic rats. Biochim. Biophys. Acta, 187, 307PubMedGoogle Scholar
  28. 28.
    Corder, C. N. and Kalkhoff, R. K. (1969). Hepatic lipid metabolism in alloxan diabetic rats. J. Lab. Clin. Med., 73, 551PubMedGoogle Scholar
  29. 29.
    Williams, W. R., Hill, R. and Chaikoff, I. L. (1960). Portal venous injection of insulin in the diabetic rat: time of induction of changes in hepatic lipogenesis, cholesterogenesis, and glycogenesis. J. Lipid Res., 1, 236PubMedGoogle Scholar
  30. 30.
    Stout, R. W. (1969). Insulin stimulation of cholesterol synthesis by arterial tissue. Lancet, 2, 467PubMedCrossRefGoogle Scholar
  31. 31.
    Stout, R. W. (1977). The effect of insulin and glucose on sterol synthesis in cultured rat arterial smooth muscle cells. Atherosclerosis, 27, 271PubMedCrossRefGoogle Scholar
  32. 32.
    Bathena, J., Avignan, J. and Schreiner, M. E. (1974). Effect of insulin on sterol and fatty acid synthesis and hydroxy methylglutaryl CoA reductase activity in mammalian cells grown in culture. Proc. Natl. Acad. Sci., USA, 71, 2174CrossRefGoogle Scholar
  33. 33.
    Lakshmanan, M. R., Nepokroeff, C. M., Ness, G. C., Dugan, R. E. and Porter, J. W. (1973). Stimulation by insulin of rat liver β-hydroxy β-methylglutaryl coenzyme A reductase and cholesterol synthesising activities. Biochem. Biophys. Res. Commun., 50, 704PubMedCrossRefGoogle Scholar
  34. 34.
    Huber, J., Guder, W., Latzin, S. and Hamprecht, B. (1973). The influence of insulin and glucagon on hydroxy-methylglutaryl coenzyme A reductase activity in rat liver. Hoppe- Seyler’s Z. Physiol. Chem., 254, 795Google Scholar
  35. 35.
    Nepokroeff, C. M., Lakshmanan, M. R., Ness, G. C., Dugan, R. E. and Porter, J. W. (1974). Regulation of the diurnal rhythm of rat liver β-methylglutaryl coenzyme A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch. Biochem. Biophys., 160, 387PubMedCrossRefGoogle Scholar
  36. 36.
    Nakayama, H. and Nakagawa, S. (1977). Influence of streptozotocin diabetes on intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in the rat. Diabetes, 26, 439PubMedCrossRefGoogle Scholar
  37. 37.
    Nervi, F. O., Genzalez, A. and Valdivieso, V. D. (1974). Studies on cholesterol metabolism in the diabetic rat. Metabolism, 23, 495PubMedCrossRefGoogle Scholar
  38. 38.
    Bennion, L. J. and Grundy, S. M. (1977). Effects of diabetes mellitus on cholesterol metabolism in man. N. Engl. J. Med., 296, 1365PubMedCrossRefGoogle Scholar
  39. 39.
    Miettinen, T. A. (1971). Cholesterol production in obesity. Circulation, 44, 842PubMedGoogle Scholar
  40. 40.
    Saudek, C. D. and Brach, E. L. (1978). Cholesterol metabolism in diabetes. Diabetes, 27, 1059PubMedCrossRefGoogle Scholar
  41. 41.
    Frier, B. M. and Saudek, C. D. (1979). Cholesterol metabolism in diabetes: the effect of insulin on the kinetics of plasma squalene. J. Clin. Endocrinol Metab., 49, 824PubMedCrossRefGoogle Scholar
  42. 42.
    Chait, A., Bierman, E. L. and Albers, J. J. (1978). Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts. Biochim. Biophys. Acta, 529, 292PubMedGoogle Scholar
  43. 43.
    Chait, A., Bierman, E. L. and Albers, J. J. (1979). Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanisms of insulin-induced stimulation. J. Clin. Invest., 64, 1309PubMedCrossRefGoogle Scholar
  44. 44.
    Chait, A., Bierman, E. L. and Albers, J. J. (1979). Low density lipoprotein receptor activity in fibroblasts cultured from diabetic donors. Diabetes, 28, 914PubMedCrossRefGoogle Scholar
  45. 45.
    Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L. and Motulsky, A. G. (1973). Hyperlipidemia in coronary heart disease. Lipid levels in 500 survivors of myocardial infarction. J. Clin. Invest., 52, 1533PubMedCrossRefGoogle Scholar
  46. 46.
    Brunzell, J. D., Hazzard, W. R., Motulsky, A. G. and Bierman, E. L. (1975). Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities. Metabolism, 24, 1115PubMedCrossRefGoogle Scholar
  47. 47.
    Buchanan, K. D. (1977). Glucagon. In Bajaj, J. S. (ed.) Insulin and Metabolis., pp. 233–70. (Amsterdam, Elsevier/North Holland: Biomedical Press)Google Scholar
  48. 48.
    Lefebvre, P. (1975). Glucagon and adipose tissue. Biochem. Pharmacol., 24, 1261PubMedCrossRefGoogle Scholar
  49. 49.
    Schade, D. S., Woodside, W. and Eaton, R. P. (1979). The role of glucagon in the regulation of plasma lipids. Metabolism, 28, 874PubMedCrossRefGoogle Scholar
  50. 50.
    Weinstein, I., Klausner, H. A. and Heimberg, M. (1973). The effect of concentration of glucagon on output of triglyceride, ketone bodies, glucose and urea by the liver. Biochim. Biophys. Acta, 296, 300PubMedGoogle Scholar
  51. 51.
    Schweppe, J. S. and Jungmann, A. A. (1969). Effect of hormones on hepatic cholesterol ester synthesis in vitro. Proc. Soc. Exp. Biol. Med., 131, 868PubMedGoogle Scholar
  52. 52.
    Friedman, M., Byers, S. O., Rosenman, R. H. and Elel, S. (1971). Effect of glucagon on blood-cholesterol levels in rats. Lancet, 2, 464PubMedCrossRefGoogle Scholar
  53. 53.
    Caren, R. and Corbo, L. (1960). Glucagon and cholesterol metabolism. Metabolism, 9, 938PubMedGoogle Scholar
  54. 54.
    Hoak, J. C., Connor, W. E. and Warner, E. D. (1968). Toxic effects of glucagon-induced acute lipid mobilisation in geese. J. Clin. Invest., 47, 2701PubMedCrossRefGoogle Scholar
  55. 55.
    Grande, F. and Prigge, W. F. (1970). Glucagon infusion, plasma FFA and triglycerides, blood sugar and liver lipids in birds. Am. J. Physiol., 218, 1406PubMedGoogle Scholar
  56. 56.
    Caren, R. and Corbo, L. (1971). Depression of plasma lipid fractions and inhibition of platelet aggregation by action of glucagon. Metabolism, 20, 1057PubMedCrossRefGoogle Scholar
  57. 57.
    Amatuzio, D. S., Grande, F. and Wada, S. (1962). Effect of glucagon on the serum lipids in essential hyperlipemia and in hypercholesterolemia. Metabolism, 11, 1240PubMedGoogle Scholar
  58. 58.
    Caren, R. and Corbo, L. (1974). Glucagon and plasma lipoprotein lipase. Proc. Soc. Exp. Biol. Med., 146, 1106PubMedGoogle Scholar
  59. 59.
    Schade, D. S. and Eaton, R. P. (1975). Modulation of fatty acid metabolism by glucagon in man. III. Role of pharmacologic limitation of FFA availability. Diabetes, 24, 1020PubMedCrossRefGoogle Scholar
  60. 60.
    Marks, V., Frizel, D., Twycross, R. G. and Buchanan, K. D. (1971). Effect of β-pyridylcarbinol on glucose tolerance, plasma glucagon, insulin and growth hormone in In Grey, K. F. and Carlson, L. A. (eds.) Metabolic Effect of Nicotinic Acid and Derivatives, pp. 961–75. (Berne: Huber)Google Scholar
  61. 61.
    Tiengo, A., Muggeo, M., Assan, R., Fedele, D. and Crepaldi, G. (1975). Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment. Metabolism, 24, 901PubMedCrossRefGoogle Scholar
  62. 62.
    Eaton, R. P. and Schade, D. S. (1973). Glucagon resistance as a hormonal basis for endogenous hyperlipaemia. Lancet, 1, 973PubMedCrossRefGoogle Scholar
  63. 63.
    Schade, D. S. and Eaton, R. P. (1977). The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man. Horm. Metab. Res., 9, 253PubMedCrossRefGoogle Scholar
  64. 64.
    Kaufmann, R. L., Assal, J. P., Soeldner, J. S., Wilmshurst, E. G., Lemaire, J. R., Gleason, R. E. and White, P. (1975). Plasma lipid levels in diabetic children. Effect of diet restricted in cholesterol and saturated fats. Diabetes, 24, 672PubMedCrossRefGoogle Scholar
  65. 65.
    Chase, H. P. and Glasgow, A. M. (1976). Juvenile diabetes mellitus and serum lipids and lipoprotein levels. Am. J. Dis. Child., 130, 1113PubMedGoogle Scholar
  66. 66.
    Chance, G. W., Albutt, E. C. and Edkins, S. M. (1969). Serum lipids and lipoproteins in untreated diabetic children. Lancet, 1, 1126PubMedCrossRefGoogle Scholar
  67. 67.
    Wilson, D. E., Schreibman, P. H., Day, V. C. and Arky, R. A. (1970). Hyperlipidemia in an adult diabetic population. J. Chron. Dis., 23, 501CrossRefGoogle Scholar
  68. 68.
    Hayes, T. M. (1972). Plasma lipoproteins in adult diabetes. Clin. Endocrinol., 1, 247CrossRefGoogle Scholar
  69. 69.
    Rodger, N. W. and Du, E. L. (1973). Some factors indicative of hypertriglyceridemia in patients investigated for diabetes mellitus. Can. Med. Assoc. J., 109, 363PubMedGoogle Scholar
  70. 70.
    Schonfeld, G., Birge, C., Miller, J. P., Kessler, G. and Santiago, J. (1974). Apolipoprotein composition in diabetes. Diabetes, 23, 827PubMedGoogle Scholar
  71. 71.
    Miller, G. J. and Miller, N. E. (1975). Plasma high-density lipoprotein concentration and the development of ischaemic heart disease. Lancet, 1, 16PubMedCrossRefGoogle Scholar
  72. 72.
    Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. and Dawber, T. R. (1977). High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med., 62, 707PubMedCrossRefGoogle Scholar
  73. 73.
    Rossner, S., Kjellin, K. G., Mettinger, K. L., Siden, A. and Soderstrom, C. E. (1978). Normal serum-cholesterol but low HDL-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet, 1, 577PubMedCrossRefGoogle Scholar
  74. 74.
    Taggart, H. and Stout, R. W. (1979). Reduced high density lipoprotein in stroke: relationship with elevated triglyceride and hypertension. Eur. J. Clin. Invest., 9, 219PubMedCrossRefGoogle Scholar
  75. 75.
    Lopes-Virella, M. F. L., Stone, P. G. and Colwell, J. A. (1977). Serum high density lipoprotein in diabetic patients. Diabetologia, 13, 285PubMedCrossRefGoogle Scholar
  76. 76.
    Paisey, R., Elkeles, R. S., Hambley, J. and Magill, P. (1978). The effects of chlorpropamide and insulin on serum lipids lipoproteins and fractional triglyceride removal. Diabetologia, 15, 81PubMedCrossRefGoogle Scholar
  77. 77.
    Kennedy, A. L., Lappin, T. R. J., Lavery, T. D., Hadden, D. R., Weaver, J. A. and Montgomery, D.A.D. (1978). Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br. Med. J., 2, 1191PubMedCrossRefGoogle Scholar
  78. 78.
    Calvert, G. D., Graham, J. J., Mannik, T., Wise, P. H. and Yeates, R. A. (1978). Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet, 2, 66PubMedCrossRefGoogle Scholar
  79. 79.
    Howard, B. V., Savage, P. J., Bennion, L. J. and Bennett, P. H. (1978). Lipoprotein composition in diabetes mellitus. Atherosclerosis, 30, 153PubMedCrossRefGoogle Scholar
  80. 80.
    Nikkila, E. A. and Hormila, P. (1978). Serum lipids and lipoproteins in insulin-treated diabetes. Diabetes, 27, 1078PubMedGoogle Scholar
  81. 81.
    Elkeles, R. S., Wu, J. and Hambley, J. (1978). Haemoglobin A, blood glucose and high-density lipoprotein cholesterol in insulin-requiring diabetes. Lancet, 2, 547PubMedCrossRefGoogle Scholar
  82. 82.
    Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. and Dawber, T. R. (1977). Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study. Ann. Intern. Med., 87, 393PubMedGoogle Scholar
  83. 83.
    Eckel, R. H., Albers, J. J., Cheung, M. C., Wahl, P. W., Lindgren, F. T. and Bierman, E. L. (1981). High density lipoprotein composition in insulin dependent diabetes mellitus. Diabetes, 30, 132PubMedCrossRefGoogle Scholar
  84. 84.
    Olefsky, J., Reaven, G. M. and Farquhar, J. W. (1974). Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J. Clin. Invest., 53, 64PubMedCrossRefGoogle Scholar
  85. 85.
    Stout, R. W., Brunzell, J. D., Porte, D. Jr and Bierman, E. L. (1974). Effect of phenformin on lipid transport in hypertriglyceridemia. Metabolism, 23, 815PubMedCrossRefGoogle Scholar
  86. 86.
    Stone, D. B. and Connor, W. E. (1963). The prolonged effects of a low cholesterol, high carbohydrate diet upon the serum lipids in diabetic patients. Diabetes, 12, 127PubMedGoogle Scholar
  87. 87.
    Sterky, G. C. G., Persson, B. E. H. and Larsson, Y. A. A. (1966). Dietary fats, the diurnal blood lipids and ketones in juvenile diabetes. Diabetologia, 2, 14PubMedCrossRefGoogle Scholar
  88. 88.
    Hockaday, T. D. R., Hockaday, J. M., Mann, J. I. and Turner, R. C. (1978). Prospective comparison of modified fat high carbohydrate with standard low carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. Br. J. Nutr., 39, 357PubMedCrossRefGoogle Scholar
  89. 89.
    Brunzell, J. D., Lerner, R. L., Hazzard, W. R., Porte, D. Jr and Bierman, E. L. (1971). Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N. Engl. J. Med., 284, 521PubMedCrossRefGoogle Scholar
  90. 90.
    Brunzell, J. D., Lerner, R. L., Porte, D., Jr and Bierman, E. L. (1974). Effect of a fat- free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes, 23, 138PubMedGoogle Scholar
  91. 91.
    Wemsier, R. L., Seeman, A., Herrera, G. M., Assal, J. P., Soeldner, J. S. and Gleason, R. E. (1974). High- and low-carbohydrate diets in diabetes mellitus. Study of effects on diabetic control, insulin secretion and blood lipids. Ann. Intern. Med., 80, 332Google Scholar
  92. 92.
    Perrett, A. D., Rowe, A. S., Shahmanesh, M., Allison, S. P. and Hartog, M. (1974). Blood lipids in treated diabetics. Diabetologia, 10, 115PubMedCrossRefGoogle Scholar
  93. 93.
    Simpson, R. W., Mann, J. I., Hockaday, T. D. R., Hockaday, J. M., Turner, R. C. and Jefls, R. (1979). Lipid abnormalities in untreated maturity-onset diabetics and the effect of treatment. Diabetologia, 16, 101PubMedCrossRefGoogle Scholar
  94. 94.
    Dunn, F. L., Pietri, A. and Raskin, P. (1981). Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type 1 diabetes mellitus. Ann. Intern. Med., 95, 426PubMedGoogle Scholar
  95. 95.
    Lisch, H. J. and Sailer, S. (1981). Lipoprotein patterns in diet, sulphonylurea and insulin treated diabetics. Diabetologia, 20, 118PubMedCrossRefGoogle Scholar
  96. 96.
    Lopes-Virella, M. F., Wohltmann, H. J., Loadholt, C. B. and Buse, M. G. (1981). Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control. Diabetologia, 21, 216PubMedCrossRefGoogle Scholar
  97. 97.
    Sosenko, J. M., Breslow, J. L., Miettinen, O. S. and Gabbay, K. H. (1980). Hyperglycemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients. N. Engl. J. Med., 302, 650PubMedCrossRefGoogle Scholar
  98. 98.
    Albrink, M. J., Lavietes, P. H. and Man, E. B. (1962). Relationship between serum lipids and the vascular complications of diabetes from 1931 to 1961. Trans. Assoc. Am. Phys., 75, 235PubMedGoogle Scholar
  99. 99.
    Reinheimer, W., Bliffen, G., McCoy, J., Wallace, D. and Albrink, M. J. (1967). Weight gain, serum lipids and vascular disease in diabetics. Am. J. Clin. Nutr., 20, 986PubMedGoogle Scholar
  100. 100.
    New, M. I., Roberts, T. N., Bierman, E. L. and Reader, G. G. (1963). The significance of blood lipid alterations in diabetes mellitus. Diabetes, 12, 208PubMedGoogle Scholar
  101. 101.
    Kudo, H. (1969). Serum triglyceride levels of untreated diabetics in relation to vascular lesions and obesity. Tohoku J. Exp. Med., 97, 47PubMedCrossRefGoogle Scholar
  102. 102.
    Santen, R. J., Willis, P. W. and Fajans, S. S. (1972). Atherosclerosis in diabetes mellitus. Arch. Intern. Med., 130, 833PubMedCrossRefGoogle Scholar
  103. 103.
    Ostrander, L. D., Neff, B. J., Block, W. D., Francis, T. and Epstein, F. H. (1967). Hyperglycemia and hypertriglyceridemia among persons with coronary heart disease. Ann. Intern. Med., 67, 34PubMedGoogle Scholar
  104. 104.
    Ostrander, L. D., Lamphiear, D. E., Carman, W. J. and Williams, G. W. (1981). Blood glucose and risk of coronary disease. Arteriosclerosis, 1, 33PubMedCrossRefGoogle Scholar
  105. 105.
    Fuller, J. H., Shipley, M. J., Rose, G., Jarrett, R. J. and Keen, H. (1980). Coronary- heart-disease risk and impaired glucose tolerance. Lancet, 1, 1373PubMedCrossRefGoogle Scholar
  106. 106.
    Garcia, M. J., McNamara, P. M., Gordon, T. and Kannel, W. B. (1974). Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes, 23, 105PubMedGoogle Scholar
  107. 107.
    Kannel, W. B. and McGee, D. L. (1979). Diabetes and cardiovascular risk factors: the Framingham Study. Circulation, 59, 8PubMedGoogle Scholar
  108. 108.
    Kannel, W. B. and McGee, D. L. (1979). Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care, 2, 120PubMedCrossRefGoogle Scholar
  109. 109.
    Reckless, J. P. D., Betteridge, D. J., Wu, P., Payne, B. and Galton, D. J. (1978). High- density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br. Med. J., 1, 883PubMedCrossRefGoogle Scholar
  110. 110.
    Beach, K. W., Brunzell, J. D., Conquest, L. L. and Strandness, D. E. (1979). The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and noninsulin-dependent diabetes. Diabetes, 28, 836PubMedGoogle Scholar

Copyright information

© R. W. Stout 1982

Authors and Affiliations

  1. 1.The Queen’s University of BelfastUK

Personalised recommendations